Dechra Pharma completes Apex Lab acquisition

Dechra Pharmaceuticals said the acquisition of the business and assets of Apex Laboratories Pty Ltd has now completed.

At 9:15am: (LON:DPH) Dechra Pharmaceuticals PLC share price was +9.5p at 1379.5p